Published: 29 May 2020
ID: G00727588
Analyst(s): Lydia Clougherty Jones
COVID-19 is reshaping privacy, yet its final contours remain unknown. A U.S. Senate bill regulating data from contact tracing applications provides insight for data and analytics leaders, disentangling consumer privacy from patient privacy while expanding data sharing as part of pandemic recovery.
Overview
Analysis
Impacts and Recommendations
Gartner Recommended Reading
Note 1: Government Contact Tracing Application Initiatives
Note 2: Examples of COVID-19 Contact Tracing Technology Bills or Laws on Initiatives
Note 3: U.S. Citizen/Consumer Sentiment and Contact Tracing Application Adoption
Note 4: Employee Screening Data
Note 5: Gartner COVID-19 Resources
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see Guiding Principles on Independence and Objectivity.